Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Capital Expenditures (2019 - 2025)

Pulmonx has reported Capital Expenditures over the past 7 years, most recently at -$63000.0 for Q3 2025.

  • Quarterly Capital Expenditures fell 105.4% to -$63000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Sep 2025, down 179.68% year-over-year, with the annual reading at $218000.0 for FY2024, 100.0% up from the prior year.
  • Capital Expenditures was -$63000.0 for Q3 2025 at Pulmonx, up from -$226000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.9 million in Q3 2021 and troughed at -$1.1 million in Q4 2024.
  • The 5-year median for Capital Expenditures is $279000.0 (2022), against an average of $233421.1.
  • Year-over-year, Capital Expenditures skyrocketed 6000.0% in 2021 and then crashed 2250.0% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $1.1 million in 2021, then crashed by 162.46% to -$717000.0 in 2022, then surged by 107.25% to $52000.0 in 2023, then crashed by 2250.0% to -$1.1 million in 2024, then skyrocketed by 94.36% to -$63000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Capital Expenditures are -$63000.0 (Q3 2025), -$226000.0 (Q2 2025), and $301000.0 (Q1 2025).